Thiosemicarbazide menthyl formate compound and preparation method and application thereof

By conducting a series of reactions of menthol with hydrazine hydrate and phenyl isothiocyanate, menthol aminothiourea formate compounds was prepared, which solved the problem of lack of targeted pesticides in the prior art and achieved the nucleus of rapeseed Effective inhibition of fungi such as pathogens and citrus cavities demonstrates its potential application in the field of pesticides.

CN119080660APending Publication Date: 2024-12-06NANJING FORESTRY UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411192333.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

There is a lack of targeted thiourea compounds in the field of pesticides, especially in antifungal, and no application of thiourea formate compounds as agricultural fungicides is found in the prior art.

Method used

The menthol esters are synthesized into chloroformate, followed by reaction with hydrazine hydrate to form hydrazine formate, and reacted with phenyl isothiocyanate to prepare a structurally novel menthiourea formate compound. The method includes synthesis of menthol chloroformate at room temperature, followed by synthesis of menthol hydrazine formate under ice bath conditions, and synthesis of menthol thiourea formate under reflux conditions at 80°C.

Benefits of technology

The prepared menthol sulfate compounds showed good inhibitory effect on plant fungi such as rapeseed bacteria, gratinum cyst bacteria and wheat gibberelliae. The preparation method is simple, the raw materials are easy to obtain, and the reaction conditions are mild. Easy to control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080660A_ABST
    Figure CN119080660A_ABST
Patent Text Reader

Abstract

The invention discloses a menthyl thiosemicarbazone formate compound as well as a preparation method and application thereof. The compound has a general formula I: # imgabs0 #, wherein R is H, 4-F, 3-F, 2-F, 4-Cl, 3-Cl, 2-Cl, 4-Br, 4-I, 4-CF3, 4-CN, 4-NO2, 4-CH3, 2-CH3, 4-OCH3 and 2, 4-diF; the compound has a good prevention effect on sclerotinia sclerotiorum and botryosphaeria dothidea under an in-vitro condition, and can be used for preventing and treating fungal diseases of agricultural or forestry plants. The preparation method of the compound is simple and convenient, the yield is high, and the product property is stable.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pesticide synthesis, and in particular relates to a thiosemicarbazide formate menthyl compound, a preparation method and an application thereof. Background Art

[0002] Crop diseases and insect pests are one of the important constraints that affect the sustainable and healthy development of agricultural products and forest resources. Pesticides, as a special commodity for controlling biological hazards such as pests and diseases of agricultural and forestry crops, play an extremely important role in protecting the normal growth of agricultural and forestry crops, improving agricultural production, and promoting food security. However, the long-term use of a single pesticide variety will also cause plant pathogens, pests and weeds to develop resistance. Therefore, the development of new pesticide varieties with targeted effects is crucial for the effective control of plant diseases.

[0003] The semicarbazide group has a wide range of applications and prospects in the fields of medicine and pesticides. In the field of pesticides, the semicarbazide group is one of the important structural units of many pesticides. In order to further develop pesticides containing the semicarbazide group and having a targeted effect, the natural product menthol is used as a raw material to activate the functional group and introduce the semicarbazide group to obtain a target compound with a novel structure and excellent antibacterial activity. Finding drug lead compounds with excellent antifungal activity has great theoretical and practical significance for the development of new antifungal pesticides and the prevention and control of agricultural and forestry crop diseases.

[0004] So far, there is no report on the use of thiosemicarbazide formate menthyl compounds as agricultural fungicides. Summary of the invention

[0005] The purpose of this section is to summarize some aspects of embodiments of the present invention and briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section and the specification abstract and the invention title of this application to avoid blurring the purpose of this section, the specification abstract and the invention title, and such simplifications or omissions cannot be used to limit the scope of the present invention.

[0006] In view of the above problems and / or the problems existing in the prior art, the present invention is proposed.

[0007] Therefore, the object of the present invention is to overcome the deficiencies in the prior art and provide a thiosemicarbazide formate menthyl compound.

[0008] In order to solve the above technical problems, the present invention provides the following technical solution: a thiosemicarbazide formate menthyl compound, characterized in that: the structural formula of the thiosemicarbazide formate menthyl compound is as follows:

[0009]

[0010] Wherein, R is selected from H, 2-F, 3-F, 4-F, 2-Cl, 3-Cl, 4-Cl, 4-Br, 4-I, 4-CF3, 2-CH3, 2-CH3, 4-OCH3, 4-NO2, 4-CN, 2,4-diF.

[0011] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a method for preparing thiosemicarbazide formate menthyl ester compounds, comprising:

[0012] Menthol is esterified to synthesize menthyl chloroformate;

[0013] Menthyl chloroformate is reacted with hydrazine hydrate to synthesize menthyl hydrazinecarboxylate;

[0014] Menthyl thiocarbazide was synthesized by the reaction of menthyl hydrazine with phenyl isothiocyanate with different substituents.

[0015] As a preferred embodiment of the preparation method of the present invention, the synthesis of menthyl chloroformate comprises:

[0016] Take menthol and solid triphosgene in a single-mouth bottle, add tetrahydrofuran as solvent, and stir at room temperature for 1 hour. Then slowly add triethylamine with a dropping funnel, react for 12 hours, and detect by TLC. After the reaction is complete, filter to remove the white solid, and concentrate the filtrate by rotary evaporation to remove tetrahydrofuran. The light yellow oil obtained is menthyl chloroformate;

[0017] Wherein, the molar ratio of the menthol, triphosgene and triethylamine reagent is 1:1.1:1.1.

[0018] As a preferred embodiment of the preparation method of the present invention, wherein: the synthesis of menthyl hydrazine carboxylate comprises:

[0019] Dissolve hydrazine hydrate and triethylamine in acetonitrile solution, add menthyl chloroformate dropwise under ice bath condition, stir for 3 hours, and detect by TLC. After the reaction is completed, concentrate under reduced pressure to remove the solvent, and dissolve the obtained product in ethanol for recrystallization to obtain menthyl hydrazinecarboxylate as a white solid;

[0020] Wherein, the molar ratio of the menthyl chloroformate, hydrazine hydrate and triethylamine reagent is 1:2:1.5.

[0021] As a preferred embodiment of the preparation method of the present invention, the synthesis of thiosemicarbazide menthyl formate comprises:

[0022] Dissolve menthyl hydrazinecarboxylate and isothiocyanate in anhydrous ethanol, reflux at 80°C, react for 3 hours, and detect that the raw materials are completely reacted by TLC. After the reaction, extract with water and ethyl acetate and wash with saturated sodium chloride. The organic phase is rotary concentrated to remove most of the ethyl acetate. Finally, the crude product is separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate;

[0023] Wherein, the molar ratio of menthyl carbazate to substituted phenyl isothiocyanate is 1:1.

[0024] As a preferred embodiment of the preparation method of the present invention, the substituted phenyl isothiocyanate includes phenyl isothiocyanate, 2-fluorophenyl isothiocyanate, 3-fluorophenyl isothiocyanate, 4-fluorophenyl isothiocyanate, 2-chlorophenyl isothiocyanate, 3-chlorophenyl isothiocyanate, 4-chlorophenyl isothiocyanate, 4-bromophenyl isothiocyanate, 4-iodophenyl isothiocyanate, 4-trifluoromethylphenyl isothiocyanate, 2-methylphenyl isothiocyanate, 4-methylphenyl isothiocyanate, 4-methoxyphenyl isothiocyanate, 4-nitrophenyl isothiocyanate, 4-cyanophenyl isothiocyanate, and 2,4-difluorophenyl isothiocyanate.

[0025] Another object of the present invention is to overcome the deficiencies in the prior art and provide a method for using a thiosemicarbazide formate menthyl compound in preventing and controlling plant fungi in agriculture or forestry, wherein the plant fungi include tomato gray mold, rapeseed sclerotinia, grape spores, wheat fusarium, pepper phytophthora and potato late blight.

[0026] Beneficial effects of the present invention:

[0027] (1) The compound described in the present invention is a thiosemicarbazide-containing menthyl formate derivative, which has a novel molecular structure and is a new compound with distinct chemical structure characteristics. The structural formula contains menthyl formate and phenyl isothiocyanate groups, wherein phenyl isothiocyanate and menthyl formate are connected by a hydrazide bond. The preparation method of the compound described in the present invention is simple, the raw materials are easily available, and the reaction conditions are mild and easy to control.

[0028] (2) The compound of the present invention is an agent for controlling plant fungi in the field of agriculture or forestry, and the agent shows good effects in controlling rapeseed sclerotinia, Botrytis cinerea and wheat fusarium. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor. Among them:

[0030] Figure 1 The schematic diagram is a method for preparing thiosemicarbazide formate menthyl ester compounds of the present invention.

[0031] Figure 2 Schematic diagram of the in vitro experiment (plate) of compound 1-14 in the examples of the present invention against Sclerotinia sclerotiorum and Botrytis cinerea (concentrations from left to right are 0 mg / L, 1.5625 mg / L, 3.125 mg / L, 6.25 mg / L, 12.5 mg / L and 25.0 mg / L).

[0032] Figure 3 Schematic diagram of the protective and therapeutic activity experiments of compound I-14 on carrots infected with Sclerotinia sclerotiorum. DETAILED DESCRIPTION

[0033] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with the embodiments of the specification.

[0034] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein, and those skilled in the art may make similar generalizations without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.

[0035] Secondly, the term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. The term "in one embodiment" that appears in different places in this specification does not necessarily refer to the same embodiment, nor does it refer to a separate or selective embodiment that is mutually exclusive with other embodiments.

[0036] The schematic diagram of the preparation method of thiosemicarbazide formate menthyl ester compounds of the present invention is shown in Figure 1 , including the following steps:

[0037] (1) Menthol (CAS: 2216-51-5, purchased from Shanghai Bid Pharmaceutical Co., Ltd.) was esterified to synthesize menthyl chloroformate;

[0038] (2) reacting menthyl chloroformate with hydrazine hydrate to synthesize menthyl hydrazine;

[0039] (3) Menthyl hydrazine carboxylate reacts with phenyl isothiocyanate with different substituents to synthesize menthyl thiosemicarbazide formate compounds;

[0040] The specific steps are:

[0041] (1) Preparation of Menthyl Chloroformate (II)

[0042] Take menthol (1g, 6.4mmol) and solid triphosgene (2.08g 7.1mmol) in a 150ml single-mouth bottle, add 20ml tetrahydrofuran to dissolve, and stir for 1h. Slowly drop 975μL of triethylamine with a dropping funnel at room temperature, react for 12h, and detect by TLC. After the reaction is complete, filter to remove the white solid, and concentrate the filtrate by rotary evaporation to remove tetrahydrofuran. The light yellow oil obtained is menthyl chloroformate;

[0043] (2) Preparation of Menthyl Hydrazate (III)

[0044] Dissolve hydrazine hydrate (53.8 μL 1.1 mmol) and triethylamine (115.7 μL 0.83 mmol) in 20 ml acetonitrile solution, and add menthyl chloroformate (120 μL 0.55 mmol) dropwise under ice bath conditions. Stir for 3 h, and detect by TLC. After the reaction is completed, concentrate under reduced pressure to remove the solvent, and dissolve the obtained product in ethanol for recrystallization to obtain a white solid, which is menthyl hydrazinecarboxylate;

[0045] (3) Preparation of Thiosemicarbazide Formate Menthyl (I)

[0046] Phenyl isothiocyanate, 2-fluorophenyl isothiocyanate, 3-fluorophenyl isothiocyanate, 4-fluorophenyl isothiocyanate, 2-chlorophenyl isothiocyanate, 3-chlorophenyl isothiocyanate, 4-chlorophenyl isothiocyanate, 4-bromophenyl isothiocyanate, 4-iodophenyl isothiocyanate, 4-trifluoromethylphenyl isothiocyanate, 2-methylphenyl isothiocyanate, 4-methylphenyl isothiocyanate, 4-methoxyphenyl isothiocyanate, 4-nitrophenyl isothiocyanate, 4-cyanophenyl isothiocyanate, 2,4-difluorophenyl isothiocyanate (1 mmol) and menthyl carbazate (1 mmol) were added to 10 mL of anhydrous ethanol solution, refluxed at 80°C, and reacted for 3 h. The reaction of the raw material was completed after monitoring by TLC. After the reaction, the mixture was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was rotary concentrated to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1 to obtain the target compound, menthyl thiosemicarbazide formate.

[0047] Example 1

[0048] Prepare menthyl hydrazine:

[0049]

[0050] Hydrazine hydrate (1mmol) and triethylamine (0.75mmol) were dissolved in 20ml acetonitrile solution, and the compound menthyl chloroformate (0.5mmol) was added dropwise under ice bath conditions. Stir for 3h, and TLC was detected. After the reaction was completed, the solvent was removed by vacuum concentration, and the obtained product was dissolved in ethanol for recrystallization to obtain the target compound menthyl hydrazinecarboxylate: white solid; yield, 89.6%, mp95.1-95.6℃; 1 H NMR (600MHz, DMSO-d6): δ8.03(s,1H),4.44(td,J=10.8,4.2Hz,1H),4.01(s,2H),1.90(d,J=11.3Hz,2H),1.63(t, J=15.2Hz,2H),1.48–1.40(m,1H),1.32–1.25(m,1H),1.08–0.99(m,1H),0.96–0.79(m,8H),0.74(d,J=7.0Hz,3H). 13 C NMR (150MHz, DMSO-d6): δ158.25,73.14,46.84,41.31,33.81,30.89,25.60,23.03,21.95,20.55,16.26.

[0051] Example 2

[0052] Prepared thiosemicarbazide formate menthyl ester derivative (I-1):

[0053]

[0054]

[0055] Phenyl isothiocyanate (1mmol) and menthyl hydrazinecarboxylate (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate derivative (I-1): white solid; yield, 65.1%, mp132.4–133.1℃; 1H NMR (600MHz, CDCl3): δ8.58(s,1H),8.18(s,1H),7.44(d,J=7.8Hz,2H),7.33(t,J=7.8Hz,2H),7.22(t,J=7.4Hz,2H),4.63(td,J=10.9,4.4Hz,1H), 2.04(d,J=11.8Hz,1H),1.98–1.90(m,1H),1.67(d,J=12.2Hz,2H),1.48– 1.37(m,2H),1.08–0.98(m,2H),0.94–0.82(m,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.23,156.94,137.24,129.18,126.73,124.91,77.37,47.18,41.06,34.16,31.51,26.33,23.51,22.08,20.84,16.50.

[0056] Example 3

[0057] Prepared thiosemicarbazide formate menthyl ester derivative (I-2):

[0058]

[0059] 2-Fluoroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-2): white solid; yield, 71.4%, mp113.8–114.5℃; 1 H NMR (600MHz, CDCl3): δ8.45(s,1H),8.26(s,1H),8.08(s,1H),7.23–7.05(m,4H),4.64(td,J=10.9,4.4Hz,1H),2.03(d,J=12.2Hz ,1H),1.96–1.86(m,1H),1.67(d,J=11.9Hz,2H),1.48–1.37(m,2H),1.08–0.98(m,2H),0.92–0.85(m,7H),0.75(d,J=6.9Hz,3H). 13C NMR (150MHz, CDCl3): δ181.33, 155.73, 154.69 (d, J = 246.5Hz), 126.65 (d, J = 8.1Hz), 125.78 (d, J = 3.0Hz), 124.89 (d, J = 10 .6Hz), 123.41 (d, J = 3.4Hz), 114.91 (d, J = 19.2Hz), 77.16, 46.35, 40.15, 33.34, 30.70, 25.58, 22.70, 21.26, 20.01, 15.62.

[0060] Example 4

[0061] Prepared thiosemicarbazide formate menthyl derivative (I-3):

[0062]

[0063] 3-Fluoroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-3): white solid; yield, 73.6%, mp137.2–138.1℃; 1 H NMR (600MHz, CDCl3): δ8.66(s,1H),8.34(s,1H),7.41(d,J=10.2Hz,1H),7.28–7.06(m,3H),6.88(t,J=7.4Hz,1H),4.65(td,J=10.9,4.4Hz, 1H),2.04(d,J=11.9Hz,1H),1.95(s,1H),1.76–1.60(m,2H),1.51–1.3 8(m,2H),1.11–0.98(m,2H),0.95–0.82(m,7H),0.76(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.14, 162.69 (d, J = 244.5Hz), 139.08 (d, J = 11.1Hz), 130.07 (d, J = 9.1Hz), 119.68, 1 13.12(d,J=20.9Hz),111.60(d,J=21.7Hz),78.07,47.22,41.07,34.14,31.56,26.37,23.51,20.83,16.50.

[0064] Example 5

[0065] Prepared thiosemicarbazide formate menthyl ester derivative (I-4):

[0066]

[0067] 4-Fluoroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-4): white solid; yield, 69.6%, mp131.4–132.5℃; 1 H NMR (600MHz, CDCl3): δ8.53(s,1H),8.24(s,1H),7.39(dd,J=8.9,4.8Hz,2H),7.13(s,1H),7.01(t,J=8.5Hz,2H),4.63(td,J=10.9,4.4Hz,1H),2 .03(d,J=12.7Hz,1H),1.98–1.90(m,1H),1.71–1.64(m,2H),1.50–1.39( m,2H),1.05(q,J=12.0Hz,2H),0.93–0.82(m,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3) δ 182.89, 161.03 (d, J = 245.0Hz), 157.17, 133.36, 127.09 (d, J = 8. 3Hz), 115.89 (d, J = 22.5Hz), 47.22, 41.09, 31.56, 26.36, 23.51, 22.09, 20.85, 16.50.

[0068] Example 6

[0069] Prepared thiosemicarbazide formate menthyl ester derivative (I-5):

[0070]

[0071] 2-Chloroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-5): white solid; yield, 65.7%, mp134.6–136.6℃; 1 H NMR (600MHz, CDCl3): δ8.68(s,1H),8.31(s,1H),8.04(s,1H),7.40(d,J=8.0Hz, 1H),7.30(t,J=7.4Hz,1H),7.16(t,J=7.3Hz,1H),6.99(s,1H),4.65(td,J=10.9 ,4.4Hz,1H),2.05(d,J=11.8Hz,1H),1.94–1.87(m,1H),1.67(d,J=11.7Hz,2H), 1.50–1.36(m,2H),1.09–0.99(m,2H),0.92–0.81(m,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ181.55,156.15,134.48,129.55,127.49,127.30,127.09 ,126.00,77.96,47.18,41.04,34.16,31.52,26.41,23.50,22.09,20.86,16.48.

[0072] Example 7

[0073] Prepared thiosemicarbazide formate menthyl derivative (I-6):

[0074]

[0075] 3-Chloroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-6): white solid; yield, 70.2%, mp128.6–129.7℃; 1H NMR (600MHz, CDCl3): δ8.70(s,1H),8.45(s,1H),7.55(s,1H),7.36(d,J=7.9Hz,1H),7.29–7.09(m,3H),4.64(td,J=10.9,4.3Hz,1H),2.0 2(d,J=11.9Hz,1H),1.95(s,1H),1.68(d,J=12.7Hz,2H),1.49–1.37(m,2H),1.10–0.99(m,2H),0.94–0.82(m,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.27,157.40,138.78,134.38,129.82,126.34,124.42 ,122.54,78.06,47.19,41.06,34.12,31.54,26.35,23.48,22.09,20.83,16.49.

[0076] Example 8

[0077] Prepared thiosemicarbazide formate menthyl derivative (I-7):

[0078]

[0079] 4-Chloroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-7): white solid; yield, 70.2%, mp142.6–144.8℃; 1 H NMR (600MHz, CDCl3): δ8.68(s,1H),8.44(s,1H),7.42(d,J=8.7Hz,2H),7.32–7.13(m,3H),4.65(td,J=10.9,4.4Hz,1H),2.04(d,J =11.9Hz,1H),1.97(s,1H),1.70(d,J=11.8Hz,2H),1.51–1.39(m,2H),1.12–1.00(m,2H),0.96–0.84(m,7H),0.76(d,J=6.9Hz,3H). 13C NMR (150MHz, CDCl3): δ182.45,157.49,136.14,131.79,129.00,125.95,78.03,47.20,41.06,34.12,31.55,26.34,23.50,22.09,20.84,16.50.

[0080] Example 9

[0081] Prepared thiosemicarbazide formate menthyl ester derivative (I-8):

[0082]

[0083] 4-Bromoisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-8): white solid; yield, 75.5%, mp141.1–142.3℃; 1 H NMR (600MHz, CDCl3): δ8.62(s,1H),8.37(s,1H),7.41(d,J=8.5Hz,2H),7.34(d,J=8.6Hz,2H),7.14(s,1H),4.63(td,J=10.9,4.4Hz,1H),2 .02(d,J=12.0Hz,1H),1.95(s,1H),1.68(d,J=11.7Hz,2H),1.50–1.37(m,2H),1.09–0.99(m,2H),0.92–0.83(m,7H),0.75(d,J=6.9Hz,3H). 13 CNMR (150MHz, CDCl3): δ182.41,157.16,136.66,131.98,126.15,119.60,78.06,47.22,41.07,34.13,31.56,26.35,23.50,22.10,20.85,16.51.

[0084] Example 10

[0085] Prepared thiosemicarbazide formate menthyl ester derivative (I-9):

[0086]

[0087]

[0088] 4-Iodoisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-9): white solid; yield, 67.6%, mp128.4–129.4℃; 1 H NMR (600MHz, CDCl3): δ8.87–8.28(m,2H),7.58(d,J=8.4Hz,2H),7.21(d,J=8.6Hz,3H),4.61(td,J=10.9,4.3Hz,1H),2. 04–1.89(m,2H),1.67(d,J=11.6Hz,2H),1.47–1.36(m,2H),1.09–0.96(m,2H),0.92–0.81(m,7H),0.73(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.13,157.32,137.82,137.40,126.33,77.96,90.63,47.13,41.01,34.07,31.49,26.30,23.46,22.09,20.82,16.50.

[0089] Embodiment 11

[0090] Prepared thiosemicarbazide formate menthyl derivative (I-10):

[0091]

[0092] 5-Trifluoromethylphenyl isothiocyanate (1mmol) and menthyl hydrazinecarboxylate (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate derivative (I-10): white solid; yield, 69.1%, mp132.9–134.1℃; 1H NMR (600MHz, CDCl3): δ8.86(s,1H),8.68(s,1H),7.62(d,J=8.2Hz,2H),7.48(d,J=7.5Hz,2H),7.19(s,1H),4.66(td,J=10.9,4.3H z,1H),2.06–1.94(m,2H),1.69(d,J=10.7Hz,2H),1.48–1.39(m,2H),1.14–0.98(m,2H),0.92–0.83(m,7H),0.76(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.41, 158.08, 140.94, 125.86 (d, J = 3.5Hz), 123.99 (q, J = 270.3Hz), 123 .66(d,J=5.7Hz),117.76,78.27,47.23,41.07,34.09,31.57,26.36,23.49,22.06,20.80,16.50.

[0093] Example 12

[0094] Prepared thiosemicarbazide formate menthyl ester derivative (I-11):

[0095]

[0096] 2-Methylisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-11): white solid; yield, 74.8%, mp134.6–135.1℃; 1 H NMR (600MHz, CDCl3): δ8.24(s,1H),7.92(s,1H),7.36(s,1H),7.29–7.12(m,4H),4.61(td,J=10.9,4.4Hz,1H),2.28(s,3H),2.03(d,J=11 .7Hz,1H),1.96–1.89(m,1H),1.67(d,J=11.6Hz,2H),1.47–1.37(m,2H),1.02(q,J=12.3Hz,2H),0.93–0.81(m,7H),0.75(d,J=6.9Hz,3H).13 C NMR (150MHz, CDCl3): δ182.93,156.56,135.32,131.21,128.28,127.74,127.01,12 2.31,77.47,47.19,41.10,34.17,31.49,26.30,23.47,22.08,20.85,17.92,16.44.

[0097] Example 13

[0098] Prepared thiosemicarbazide formate menthyl derivative (I-12):

[0099]

[0100] 4-Methylisothiocyanate (1mmol) and menthyl hydrazinecarboxylate (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate derivative (I-12): white solid; yield, 66.5%, mp130.1–131.2℃; 1 H NMR (600MHz, CDCl3): δ8.55(d,J=9.7Hz,1H),8.15(s,1H),7.28(d,J=8.1Hz,3H),7.13(d,J=7.8Hz,2H),4.61(td,J=10.9,4.2Hz,1H),2.32(s,3H), 2.02(d,J=12.0Hz,1H),1.99–1.90(m,1H),1.66(d,J=12.2Hz,2H),1.48– 1.36(m,2H),1.07–0.96(m,2H),0.94–0.81(m,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.34,156.85,136.69,134.56,129.73,125.15,77 .56,47.13,40.01,34.13,31.46,26.27,23.47,22.05,21.12,20.82,16.47.

[0101] Embodiment 14

[0102] Prepared thiosemicarbazide formate menthyl ester derivative (I-13):

[0103]

[0104] 4-Methoxyphenyl isothiocyanate (1mmol) and menthyl hydrazinecarboxylate (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate derivative (I-13): white solid; yield, 67.9%, mp154.1–155.6℃; 1 H NMR (600MHz, CDCl3): δ8.46(s,1H),8.08(s,1H),7.43–7.10(m,3H),6.86(d,J=8.7Hz,2H),4.61(td,J=10.9,4.3Hz,1H),3.78(s,3H),2.03(d,J=1 1.7Hz,1H),1.98–1.88(m,1H),1.66(d,J=11.7Hz,2H),1.47–1.36(m,2H) ,1.08–0.98(m,2H),0.88(dd,J=10.5,6.8Hz,7H),0.75(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.76,158.41,156.83,129.89,127.07,114.42,77 .56,55.56,47.17,41.05,34.16,31.50,26.30,23.50,22.07,20.84,16.49.

[0105] Embodiment 15

[0106] Prepared thiosemicarbazide formate menthyl derivative (I-14):

[0107]

[0108] 4-Nitroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-14): yellow solid; yield, 75.1%, mp154.5–155.9℃; 1 H NMR (600MHz, CDCl3): δ9.14(s,1H),8.78(s,1H),8.06(d,J=8.0Hz,2H),7.74(d,J=8.7Hz,2H),7.05(s,1H),4.71(td,J=10.9,4.3H z,1H),2.05(d,J=11.6Hz,2H),1.75–1.66(m,2H),1.52–1.41(m,2H),1.16–1.01(m,2H),0.97–0.87(m,7H),0.79(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.09,159.36,144.16,143.94,124.26,122.18,78.43,47.14,40.99,33.99,31.53,26.27,23.41,22.07,20.75,16.49.

[0109] Example 16

[0110] Prepared thiosemicarbazide formate menthyl derivative (I-15):

[0111]

[0112] 4-Cyanisothiocyanic acid phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-15): white solid; yield, 75.1%, mp153.1–154.5℃; 1H NMR (600MHz, CDCl3): δ8.99(s,1H),8.67(s,1H),7.69(d,J=8.3Hz,2H),7.50(d,J=7.7Hz,2H),7.17–7.02(m,1H),4.68(td,J=10.9,4.3 Hz,1H),2.03(d,J=11.9Hz,2H),1.70(d,J=10.7Hz,2H),1.50–1.42(m,2H),1.13–1.01(m,2H),0.93–0.86(m,7H),0.76(d,J=6.9Hz,3H). 13 C NMR (150MHz, CDCl3): δ182.06,158.34,142.28,132.55,122.99,118.74,107.99 ,78.24,47.13,40.99,34.00,31.50,26.26,23.42,22.04,20.74,16.47,14.18.

[0113] Embodiment 17

[0114] Prepared thiosemicarbazide formate menthyl derivative (I-16):

[0115]

[0116] 2,4-difluoroisothiocyanate phenyl ester (1mmol) and hydrazinocarboxylic acid menthyl ester (1mmol) were added to 10mL of anhydrous ethanol solution, refluxed at 80℃, and reacted for 3h. TLC detected that the raw material reacted completely. After the reaction, it was extracted with water and ethyl acetate and washed with saturated sodium chloride. The organic phase was concentrated by rotation to remove most of the ethyl acetate. Finally, the crude product was separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound thiosemicarbazide formic acid menthyl ester derivative (I-16): white solid; yield 71.5%, mp132.1–133.9℃; 1 H NMR (600MHz, CDCl3): δ8.38 (s, 2H), 7.89 (s, 1H), 7.22 (s, 1H), 6.86 (ddt, J = 10.9, 5.8, 3.0Hz, 2H), 4.62 (td, J = 10.9, 4.4Hz, 1H), 2.01 (d, J = 11. 9Hz,1H),1.90(dt,J=11.0,5.3Hz,1H),1.67(d,J=11.7Hz,2H),1.49–1. 36(m,2H),1.08–0.98(m,2H),0.94–0.81(m,7H),0.74(d,J=6.9Hz,3H). 13C NMR (150MHz, CDCl3): δ182.73,160.89(dd,J=248.3,11.8),156.70,156.16(dd,J=244.8,7.8Hz),128.57,122.02(dd,J=11.6,3.9Hz ), 111.21 (dd, J = 21.9, 3.5Hz), 104.29 (dd, J = 26.5, 23.6Hz), 78.07, 47.15, 40.97, 34.12, 31.53, 26.38, 23.50, 22.06, 20.82, 16.42.

[0117] Embodiment 18

[0118] Under certain conditions, the effect of the ratio of menthyl carbazate to phenyl isothiocyanate on the product yield was investigated. The conditions and results are shown in Table 1.

[0119] Table 1

[0120]

[0121] It can be seen that the preferred range of the ratio of menthyl hydrazine carboxylate (mmol) to phenyl isothiocyanate (mmol) is 1:0.8-1:1. Beyond this range, the yield of the obtained product decreases. Wherein, yield = [actual amount of target product produced (mg) / theoretical amount of target product produced (mg)]*100%.

[0122] Embodiment 19

[0123] Bactericidal activity (in vitro) experiment:

[0124] All the test strains in this experiment were purchased from the official website of China Agricultural Microbial Culture Collection (ACCC) and China Forestry Microbial Culture Collection (CFCC), including Botrytis cinerea (ACCC 36027), Sclerotinia sclerotiorum (ACCC 30096), Botrytis cinerea (ACCC 36164), Gibberella fusiformis (ACCC 31060), Phytophthora capsici (ACCC 36279), and Phytophthora infestans (ACCC 36164). MYA-1113 TM). The culture medium used is potato agar glucose medium (PDA for short). PDA culture medium formula: 200g potato (peeled), 20g glucose, 15g agar, 1000mL distilled water, preparation method: wash and peel the potato, weigh 200g and cut into small pieces, add water and cook until soft (boil for 20-30 minutes, until it can be pierced by a glass rod), filter into a beaker with eight layers of gauze, add 15-20g agar according to experimental needs, add 20g glucose, stir evenly, cool slightly after fully dissolved, add water to 1000mL, sterilize at 121℃ for 15 minutes after packaging, and set aside after cooling.

[0125] Experimental method: Growth rate method was used.

[0126] (1) First, culture the six plant fungi on a PDA plate at 25°C for about 3-6 days for later use;

[0127] (2) Heat and melt the PDA culture medium, cool it to 45-50°C, add 50 mg / L of the compound to be tested to prepare a culture medium containing 50 mg / L of the drug solution, and pour it into culture dishes to cool. Thiothiocarbamide is used as a positive control;

[0128] (3) Using aseptic operation procedures, use a cork puncher to punch a round bacterial cake (0.50 cm in diameter) at the edge of the hyphae of each strain after 6 days of culture (the growth conditions should be as consistent as possible), then use an inoculation needle to pick it to the center of the drug-containing plate, and then place the culture dish upside down in an incubator (28°C) for culture;

[0129] (4) Observe and measure the growth of mycelium at different times after treatment, measure the diameter using the cross method, process the data, and calculate the inhibition rate;

[0130] (5) Inhibition rate (%) = (control mycelium diameter - treated mycelium diameter) / (control mycelium diameter - 0.5) × 100; (6) Each treatment was repeated 3 times.

[0131] Table 2 Results of the inhibitory activity test of thiosemicarbazide formate menthyl ester compounds against six agricultural pathogenic fungi

[0132]

[0133]

[0134] Note: Each treatment was repeated three times in the experiment, and the data in the table are the average values ​​of the three repetitions.

[0135] Table 3 EC values ​​of some compounds 50 Value (mg / L)

[0136]

[0137] The results of the bactericidal activity determination of the experimental groups I-1 to I-16 and the control agent thiophanate-methyl are shown in Tables 2 and 3. As can be seen from Tables 2 and 3, at a concentration of 50 mg / L, compounds I-1 to I-16 showed different degrees of antibacterial activity against 6 plant fungi, and some compounds showed relatively good antibacterial activity against rapeseed sclerotinia, and moderate to good inhibitory activity against grape seat cavity fungi and tomato gray mold fungi. The inhibition rate of some compounds against rapeseed sclerotinia fungi was higher than that of the control agent thiophanate-methyl. Among them, the inhibition rate of compounds I-2, I-4, I-7, I-11, I-12, I-14 and I-15 against rapeseed sclerotinia fungi at a concentration of 50 mg / L reached more than 85%, which was better than thiophanate-methyl (81.7%). In addition, the inhibition rate of I-7, I-14 and I-15 against grape seat cavity fungi reached more than 85%, which was better than thiophanate-methyl (25.7%). Compounds I-5, I-6 and I-13 have poor antibacterial effects on the six fungi, less than 50%, indicating that the introduction of non-random thiosemicarbazide carboxylic acid can achieve good antibacterial effects.

[0138] Considering that some target compounds have good inhibitory activity against Sclerotinia sclerotiorum and Botrytis cinerea, the EC values ​​of some compounds with higher inhibition rates were tested. 50 value.

[0139] like Figure 2 As shown, the growth rate method was used to treat rapeseed sclerotinia and Botrytis cinerea with different concentrations of compound 1-14 (from left to right, the concentrations are 0 mg / L, 1.5625 mg / L, 3.125 mg / L, 6.25 mg / L, 12.5 mg / L and 25.0 mg / L). It can be concluded from the figure that the inhibitory effect of the compound is significantly affected by the concentration, and the higher the concentration of the compound, the better the inhibitory effect.

[0140] As can be seen from Table 3, the EC values ​​of the target compounds against Sclerotinia sclerotiorum 50 The activity of compound I-14 against Sclerotinia sclerotiorum EC 50 The value reached 1.03 mg / L, which was better than the positive control drug thiothiocarbamide 1.32 mg / L. In addition, the EC values ​​of some compounds against Botrytis cinerea 50 The value was better than that of the positive control thiazole amide. Compound I-14 had an EC 50 The value reached 5.88 mg / L, which is much lower than the EC of the positive control drug thiothiocarb 50 This series of compounds has good inhibitory activity against several fungi and has the potential to be developed into antifungal agents.

[0141] Embodiment 20

[0142] Bactericidal in vivo experiment:

[0143] The carrots with uniform texture and size purchased from the market were washed with sterile water, then washed with 75% ethanol, and dried in the shade at room temperature.

[0144] Weigh compound I-14 and thiofuranamide and dissolve them in 0.2% Tween-80 aqueous solution to prepare three concentrations of 200 mg / L, 100 mg / L and 50 mg / L. Then spray the surface of the cabbage (spray volume is 3 ml, one concentration), spray evenly, and then dry naturally in the shade. After there is no liquid on the carrot skin, scratch the skin with a blade, the scratch area is 3mm, and inoculate rapeseed sclerotium fungus cakes (0.5mm diameter). Inoculate 3 cakes of each concentration on three carrots, the positive control is thiofuranamide, and the blank control is DMSO. After the plants are placed (25±2℃ and 95% relative humidity) for 6 days, the diameter of the lesions is measured and the inhibition rate is calculated. The calculation formula of the inhibition rate (%) is: (blank control lesion diameter-test compound lesion diameter) / (blank control lesion diameter-0.5)×100.

[0145] Table 4 Biological activity of compound I-14 and thiothiocarb against Sclerotinia sclerotiorum

[0146]

[0147]

[0148] As shown in Table 4 and Figure 3 As shown, for protective activity, the colony diameters of different concentrations of I-14 and fluazolamide on the 6th day were significantly smaller than those of the blank control. At 50 mg / L, 100 mg / L and 200 mg / L, the inhibition rates of I-14 were 61.0, 78.2 and 97.6%, respectively, slightly better than thiophanate-methyl (56.6, 71.7 and 95.6%). In terms of therapeutic activity, the inhibition rates of I-14 at 50 mg / L, 100 mg / L and 200 mg / L were 41.7, 69.3 and 95.3%, respectively, which were stronger than thiophanate-methyl (29.8, 68.0 and 95.5%), especially in the low-dose group. These results show that compound I-14 is an excellent antibacterial agent and a sclerotinia agent with the potential to prevent and control carrot postharvest rot.

[0149] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention can be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the present invention.

Claims

1. A thiosemicarbazide formate menthyl compound, characterized in that: The structural formula of the thiosemicarbazide formate menthyl compound is as follows: Wherein, R is selected from H, 2-F, 3-F, 4-F, 2-Cl, 3-Cl, 4-Cl, 4-Br, 4-I, 4-CF3, 2-CH3, 2-CH3, 4-OCH3, 4-NO2, 4-CN, 2,4-diF.

2. The method for preparing the thiosemicarbazide formate menthyl compound according to claim 1, characterized in that: include, Menthol is esterified to synthesize menthyl chloroformate; Menthyl chloroformate is reacted with hydrazine hydrate to synthesize menthyl hydrazinecarboxylate; Menthyl thiocarbazate was synthesized by the reaction of menthyl hydrazine with phenyl isothiocyanate with different substituents.

3. The preparation method according to claim 2, characterized in that: The synthesis of menthyl chloroformate comprises: Take menthol and solid triphosgene in a single-mouth bottle, add tetrahydrofuran as solvent, and stir at room temperature for 1 hour. Then slowly add triethylamine with a dropping funnel, react for 12 hours, and detect by TLC. After the reaction is complete, filter to remove the white solid, and concentrate the filtrate by rotary evaporation to remove tetrahydrofuran. The light yellow oil obtained is menthyl chloroformate; Wherein, the molar ratio of the menthol, triphosgene and triethylamine reagent is 1:1.1:1.

1.

4. The preparation method according to claim 2, characterized in that: The synthetic menthyl hydrazine carboxylate comprises: Dissolve hydrazine hydrate and triethylamine in acetonitrile solution, add menthyl chloroformate dropwise under ice bath condition, stir for 3 hours, and detect by TLC. After the reaction is completed, concentrate under reduced pressure to remove the solvent, and dissolve the obtained product in ethanol for recrystallization to obtain menthyl hydrazinecarboxylate as a white solid; Wherein, the molar ratio of the menthyl chloroformate, hydrazine hydrate and triethylamine reagent is 1:2:1.

5.

5. The preparation method according to claim 2, characterized in that: The synthetic thiosemicarbazide formate menthyl ester comprises: Dissolve menthyl hydrazinecarboxylate and isothiocyanate in anhydrous ethanol, reflux at 80°C, react for 3 hours, and detect that the raw materials are completely reacted by TLC. After the reaction, extract with water and ethyl acetate and wash with saturated sodium chloride. The organic phase is rotary concentrated to remove most of the ethyl acetate. Finally, the crude product is separated and purified by 200-300 mesh silica gel column chromatography, with a petroleum ether / ethyl acetate volume ratio of 10:1 to 4:1, to obtain the target compound menthyl thiosemicarbazide formate; Wherein, the molar ratio of menthyl carbazate to substituted phenyl isothiocyanate is 1:

1.

6. The preparation method according to claim 2, characterized in that: The substituted phenyl isothiocyanate includes phenyl isothiocyanate, 2-fluorophenyl isothiocyanate, 3-fluorophenyl isothiocyanate, 4-fluorophenyl isothiocyanate, 2-chlorophenyl isothiocyanate, 3-chlorophenyl isothiocyanate, 4-chlorophenyl isothiocyanate, 4-bromophenyl isothiocyanate, 4-iodophenyl isothiocyanate, 4-trifluoromethylphenyl isothiocyanate, 2-methylphenyl isothiocyanate, 4-methylphenyl isothiocyanate, 4-methoxyphenyl isothiocyanate, 4-nitrophenyl isothiocyanate, 4-cyanophenyl isothiocyanate, and 2,4-difluorophenyl isothiocyanate.

7. Use of the thiosemicarbazide formate menthyl compound as claimed in claim 1 in preventing and controlling plant fungi in agriculture or forestry.

8. The use according to claim 7, characterized in that: The plant fungi include tomato gray mold, rapeseed sclerotinia, grape spore fungus, wheat fusarium, pepper phytophthora and potato late blight.